Medco Layoff Hits Quietly

 

Some Medco (MHS) employees have a bitter pill to swallow.

Nine hundred workers -- nearly 7% of the company's staff -- learned on Friday that they will soon lose their jobs or be transferred to another location. Medco has decided to shut down a big facility in Parsippany, N.J., that currently houses a mail-order pharmacy and a customer call center. The giant pharmacy benefit manager reached its decision after losing some major contracts amid a federal probe of its business practices.

Medco quietly informed affected employees of the layoffs Friday morning but, by Monday, had yet to issue a public announcement. The company did, however, confirm the news when contacted by TheStreet.com.

Medco spokeswoman Soraya Rodriguez-Balzac described the action as a "difficult decision" that will nevertheless enhance the efficiency of the company's overall operations. She blamed outdated technology and rising rent -- not employee performance -- for the pending closure. But she stressed that "several hundred" of the workers will be transferred to another facility.

Still, one Medco employee said the company seemed to be treating the layoffs like a "non-event."

"There is nothing written down and handed out by the company," another employee said in an email to TheStreet.com. "The company has still refused to post the announcement to their investor Web site."

Medco is making the cuts after losing business -- most notably its contract with the federal government -- to competitor Caremark (CMX). Medco is the target of a federal whistleblower lawsuit that accuses the company of, among other things, destroying prescriptions and favoring expensive drugs manufactured by former parent Merck (MRK). The company has already agreed to pay $29 million to settle similar allegations levied by 20 different states.

Rodriguez-Balzac dismissed any connection between the layoffs and lost business. But at least one Parsippany employee viewed the situation differently.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,772.77 1,341.05 2,908.17 19.67
Oil *
117.36
DOWN
117.69
DOWN
10.90
DOWN
19.06
DOWN
0.80
10 Yr
1.97%
SPDR Gold
166.94
-0.91%
-0.81%
-0.65%
-3.91%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet